| 000 | 01337 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250513185834.0 | ||
| 264 | 0 | _c19990915 | |
| 008 | 199909s 0 0 eng d | ||
| 022 | _a0098-6577 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSakurai, M | |
| 245 | 0 | 0 |
_aRapid normalization of interleukin-8 production after low-density lipoprotein apheresis in steroid-resistant nephrotic syndrome. _h[electronic resource] |
| 260 |
_bKidney international. Supplement _cJul 1999 |
||
| 300 |
_aS210-2 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aBlood Component Removal |
| 650 | 0 | 4 |
_aChemokine CCL2 _xblood |
| 650 | 0 | 4 | _aDrug Resistance |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlomerulonephritis, Membranous _xblood |
| 650 | 0 | 4 |
_aGlomerulosclerosis, Focal Segmental _xblood |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterleukin-8 _xblood |
| 650 | 0 | 4 |
_aLeukocytes, Mononuclear _xcytology |
| 650 | 0 | 4 |
_aLipoproteins, LDL _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNephrotic Syndrome _xblood |
| 650 | 0 | 4 |
_aSteroids _xtherapeutic use |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xmetabolism |
| 700 | 1 | _aMuso, E | |
| 700 | 1 | _aMatushima, H | |
| 700 | 1 | _aOno, T | |
| 700 | 1 | _aSasayama, S | |
| 773 | 0 |
_tKidney international. Supplement _gvol. 71 _gp. S210-2 |
|
| 999 |
_c10370858 _d10370858 |
||